Information is available here to support the clinical practice of the delivery of advanced therapies to patients, including patient assessment, handling advanced therapies, product administration, infusion, treatment and monitoring and recording treatment and side-effects.
PDF
18.10.2021
This exemplar guideline suggests roles and responsibilities between CAR T cell referring centres and treatment centres. It also outlines common late adverse effects that may occur when patients have returned to their referring centre.
PDF
23.08.2022
An example SOP from University Hospitals Bristol and Weston NHS Foundation Trust to provide a safe and effective framework by which lymphodepletion can be performed in the outpatient setting, prior to admission for CAR-T Cell infusion.
PDF
01.06.2020
A document summarising the challenges and solutions the the collection of starting materials for ATMP manufacture though apheresis
PDF
23.08.2022
An example SOP from University Hospitals Bristol and Weston NHS Foundation Trust detailing the inclusion and exclusion criteria when referring patients to the Ambulatory Care (AC) BMT service.
External link
13.04.2021
The CAR T cell patient journey from a nursing perspective, some of the challenges faced, and a some of patient case studies.
PDF
19.10.2021
This document sets out an example generic checklist for receipt and storage of fresh, autologous, cellular Advanced Therapy Medicinal Products.
PDF
11.06.2021
Form to complete when receiving, processing and releasing fresh cells for manufacturing
PDF
15.09.2021
A checklist to confirm ATMP is received appropriately from the manufacturer prior to administration to a patient
PDF
Job Description detailing the key responsibilities, skills and behaviours applicable for an Aseptics and Cellular Therapies Pharmacist
PDF
31.05.2022
An overview of points to consider and SOPs required when establishing a new pathway for the collection of tissues to isolate tumour infiltrating lymphocytes (TIL). Relevant for both research and clinical tissue collection.
PDF
21.06.2020
Example of a patient consent form for CAR-T therapy to treat Relapsed/ Refractory Acute Lymphoblastic Leukemia
PDF
01.06.2020
Example of a patient consent form for CAR-T therapy to treat Diffuse Large B-Cell Lymphoma
PDF
31.05.2022
SOP re: consenting Hepato-Pancreatico-Biliary (HBP) patients for biobank